Johnson & Johnson (NYSE:JNJ)

163.22
Delayed Data
As of Oct 03
 -0.14 / -0.09%
Today’s Change
155.72
Today|||52-Week Range
186.69
-4.59%
Year-to-Date
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
Oct 03 / Zacks.com - Paid Partner Content
2 Perfect Index Funds to Buy in a Bear Market
Sep 30 / MotleyFool.com - Paid Partner Content
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
Oct 03 / Zacks.com - Paid Partner Content
Why This Stock's 2.7% Dividend Yield Could Be the Safest on Wall Street
Sep 30 / MotleyFool.com - Paid Partner Content
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
Oct 03 / Zacks.com - Paid Partner Content
The Best Value Stock to Buy for the Long Term
Sep 29 / StockNews.com - Paid Partner Content
2 Stocks to Add to Your Must-Buy List in Q4
Oct 03 / StockNews.com - Paid Partner Content
Is Johnson & Johnson a Buy?
Sep 29 / MotleyFool.com - Paid Partner Content
Where to Invest $1,500 Right Now
Oct 01 / MotleyFool.com - Paid Partner Content
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
Sep 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close163.36
Today’s open164.60
Day’s range161.77 - 165.73
Volume8,656,972
Average volume (3 months)7,145,961
Market cap$429.5B
Data as of 4:00pm ET, 10/03/2022

Growth & Valuation

Earnings growth (last year)+41.93%
Earnings growth (this year)+3.03%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+13.55%
P/E ratio23.8
Price/Sales4.88
Price/Book5.80

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-1.66-0.51%
PFEPfizer+0.36+0.82%
ABBVAbbVie+4.11+3.06%
MRKMerck+1.47+1.71%
Data as of 4:00pm ET, 10/03/2022

Financials

Next reporting dateOctober 18, 2022
EPS forecast (this quarter)$2.52
Annual revenue (last year)$93.8B
Annual profit (last year)$20.9B
Net profit margin22.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New Brunswick, New Jersey

Forecasts